Ken Research - Batten Disease Pipeline Review, H1 2018

Batten Disease Pipeline Review, H1 2018
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Batten
Disease-Pipeline Review, H1 2018, provides an overview of the Batten Disease (Central
Nervous System) pipeline landscape.
Batten disease, a rare genetic disorder, belongs to a group of progressive degenerative
neurometabolic disorders known as the neuronal ceroid lipofuscinoses. Symptoms of Batten
disease usually become apparent between five and 15 years of age. Symptoms include vision
loss, lack of muscle coordination, mental retardation or decreasing mental function,
emotional disturbances, seizures, muscle spasms, deterioration of muscle tone and movement
problems.
Report Highlights
Global Markets Direct Pharmaceutical and Healthcare latest pipeline guide Batten
Disease-Pipeline Review, H1 2018, provides comprehensive information on the therapeutics
under development for Batten Disease (Central Nervous System), complete with analysis by
stage of development, drug target, mechanism of action (MoA), route of administration
(RoA) and molecule type. The guide covers the descriptive pharmacological action of the
therapeutics, its complete research and development history and latest news and press
releases.
The Batten Disease (Central Nervous System) pipeline guide also reviews of key players
involved in therapeutic development for Batten Disease and features dormant and
discontinued projects. The guide covers therapeutics under Development by Companies
/Universities /Institutes, the molecules developed by Companies in Phase II, Preclinical and
Discovery stages are 1, 10 and 2 respectively. Similarly, the Universities portfolio in Phase II,
Phase I, Preclinical and Discovery stages comprises 1, 1, 3 and 1 molecules, respectively.
Batten Disease (Central Nervous System) pipeline guide helps in identifying and tracking
emerging players in the market and their portfolios, enhances decision making capabilities
and helps to create effective counter strategies to gain competitive advantage. The guide is
built using data and information sourced from Global Markets Direct's proprietary databases,
company/university websites, clinical trial registries, conferences, SEC filings, investor
presentations and featured press releases from company/university sites and industry-specific
third party sources. Additionally, various dynamic tracking processes ensure that the most
recent developments are captured on a real time basis.
Note: Certain content / sections in the pipeline guide may be removed or altered based on the
availability and relevance of data.
Key Topics Covered in this Report:



Batten Disease Pipeline Market Research Report
Batten Disease Pipeline Market Industry Analysis
Batten Disease Pipeline Market Volume Sales